Form D · Other Health Care
FundRx, Inc.
New York, NY · CIK 0001707032
Offering snapshot reported May 19, 2017 · SEC filing
- Reported sold
- $1.39M Offering amount: $5M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2017 | Initial | $1,391,975 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287114
Total amount sold includes the value of cancelled indebtedness formerly held by certain purchasers in the aggregate principal and interest amount of $736,978.44.
Offer and sale of Series Seed and Series Seed-1 Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof.
Source: Form D, filed May 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mohammad Jainal Bhuiyan | Director |
| Gurdane Bhutani | Director, Executive |
| Aziz Hashim | Director |
| Zeshan Muhammedi | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
71 Broadway Level 2 B #102
New York, NY, 10006
New York, NY, 10006